Multinationals Face Hotter Competition In China To Hire Medical Affairs Specialists
This article was originally published in PharmAsia News
Multinationals in China are now up against fast-moving domestic firms for top medical affairs talent, a broad role that includes late stage development and post market support for drugs and devices. Hiring is not only about salary, as experts tell PharmAsia News.
You may also be interested in...
After winning a major procurement contract, BeiGene now may need to find an alternative manufacturing site for Celgene's Abraxane to supply China.
A former pharma executive shares views with Scrip about the coronavirus in China, the challenges facing corporations and individuals in a rapidly changing world and coming threats that could potentially cause even more damage than the pandemic.
Leveraging its Ebola vaccine success, Tianjin-based CanSino is looking to launch China’s first vaccine for COVID-19 as it secures permission to start local clinical trials.